154 related articles for article (PubMed ID: 20049165)
1. The potential to forgo social welfare gains through overrelianceon cost effectiveness/cost utility analyses in the evidence base for public health.
Cohen DR; Patel N
J Environ Public Health; 2009; 2009():107927. PubMed ID: 20049165
[TBL] [Abstract][Full Text] [Related]
2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
3. On aggregating QALYs: a comment on Dolan.
Johannesson M
J Health Econ; 1999 Jun; 18(3):381-6. PubMed ID: 10537901
[TBL] [Abstract][Full Text] [Related]
4. On the economic foundations of CEA. Ladies and gentlemen, take your positions!
Brouwer WB; Koopmanschap MA
J Health Econ; 2000 Jul; 19(4):439-59. PubMed ID: 11010234
[TBL] [Abstract][Full Text] [Related]
5. Theory and methods of economic evaluation of health care.
Johannesson M
Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
[No Abstract] [Full Text] [Related]
6. The Big Society needs robust public health evaluation.
Evans D
J Public Health (Oxf); 2011 Mar; 33(1):11-2. PubMed ID: 21345887
[No Abstract] [Full Text] [Related]
7. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
Dolan P; Edlin R
J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
[TBL] [Abstract][Full Text] [Related]
8. The welfare loss of disease and the theory of taxation.
Philipson T
J Health Econ; 1995 Aug; 14(3):387-95. PubMed ID: 10145141
[No Abstract] [Full Text] [Related]
9. Production gains from health care: what should be included in cost-effectiveness analyses?
Olsen JA; Richardson J
Soc Sci Med; 1999 Jul; 49(1):17-26. PubMed ID: 10414837
[TBL] [Abstract][Full Text] [Related]
10. Welfare gains and losses caused by clinical practice guidelines.
Gandjour A
Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):27-33. PubMed ID: 24328929
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective.
Remme M; Martinez-Alvarez M; Vassall A
Value Health; 2017 Apr; 20(4):699-704. PubMed ID: 28408014
[TBL] [Abstract][Full Text] [Related]
12. Measurement of QALYS and the welfare implications of survivor consumption and leisure forgone.
Nyman JA
Health Econ; 2011 Jan; 20(1):56-67. PubMed ID: 19946890
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
Birch S; Gafni A
J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
[TBL] [Abstract][Full Text] [Related]
14. How to develop cost-conscious guidelines.
Eccles M; Mason J
Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
[TBL] [Abstract][Full Text] [Related]
15. Drawing a veil over the measurement of social welfare--a reply to Johannesson.
Dolan P
J Health Econ; 1999 Jun; 18(3):387-90. PubMed ID: 10537902
[No Abstract] [Full Text] [Related]
16. Economic evaluations and randomized trials in spinal disorders: principles and methods.
Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
[TBL] [Abstract][Full Text] [Related]
17. Accounting for the missing opportunity costs in incremental cost-outcome analysis.
Oliver A
Appl Health Econ Health Policy; 2002; 1(4):191-6. PubMed ID: 14619248
[TBL] [Abstract][Full Text] [Related]
18. Is economic evaluation in touch with society's health values?
Coast J
BMJ; 2004 Nov; 329(7476):1233-6. PubMed ID: 15550430
[TBL] [Abstract][Full Text] [Related]
19. On the welfare theoretic foundation of cost-effectiveness analysis-the case when survival is not affected.
Liljas B
Eur J Health Econ; 2010 Feb; 11(1):5-13. PubMed ID: 19255794
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
